| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 257.0 | 218.3 | 198.0 |
| Other income | 11.2 | 18.5 | 12.1 |
| Total income | 268.2 | 236.7 | 210.1 |
| Profit before exceptional items & tax | 44.9 | 43.4 | 23.4 |
| Exceptional items | 0.0 | -2.5 | 0.0 |
| Profit before tax | 44.9 | 40.9 | 23.4 |
| Net profit | 37.0 | 24.8 | 16.7 |
| Operating margin | 16.7% | 17.3% | 11.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +121.60% |
|---|---|
| Net profit, quarter on quarter | +49.20% |
| Revenue, year on year | +29.80% |
BSE results filing, NSE: BLISSGVS. Figures extracted from the filing.
Bliss GVS Pharma Ltd: key numbers
- Share price
- ₹704.70
- Market cap
- ₹7,493 Cr
- Revenue (annual)
- ₹927.1 Cr
- Net profit (annual)
- ₹129.1 Cr
- P/E (TTM)
- 55.0×Sector 50.4×
- Promoter holding
- 35.01%-0.35% QoQ
- FII holding
- 8.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bliss GVS Pharma Ltd
All →Bliss GVS Pharma Annual General Meeting
Bliss GVS Pharma Ltd reported the voting results of its postal ballot. Members approved the appointment of Mr. Santosh Parab as a Non-Executive and Non-Independent Director.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma allotted equity shares under its Employee Stock Option Scheme (ESOP). This increases the company's total paid-up share capital.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma allotted 55,250 equity shares under its Employee Stock Option Plan 2019 at an exercise price of Rs. 43 per share.
- Value
- ₹0.24 Cr
Bliss GVS Pharma Open Offer: ₹0.05 Cr
Anupam Rasayan India Ltd completed an open offer to acquire 26% of Bliss GVS Pharma Ltd. Only 1,669 shares were acquired for ₹4.99 Lakh.
- Value
- ₹0.05 Cr
Bliss GVS Pharma Q1 FY27 Results: Net Profit ₹51.4 Cr, Up 15.8% YoY
Bliss GVS Pharma Ltd reported revenue from operations of ₹285.6 Cr (+37.6% YoY) and net profit of ₹51.4 Cr (+15.8% YoY) for Q1 FY27.
- Key figure
- Net profit ₹51.4 Cr · +15.8% YoY